UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services

Publication Date


Document Type



Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Pharmacoeconomics and Pharmaceutical Economics | Pharmacy Administration, Policy and Regulation


This presentation provides an overview of the hepatitis C virus monitoring program implemented for state Medicaid to contain costs and to promote optimal member care. Key clinical and economic outcomes of the monitoring program are highlighted and formulary management strategies for novel hepatitis C virus agents identified.

Presented at the American Drug Utilization Review Society 2015 Conference.


Hepatitis C medication management, Medicaid, pharmacy, clinical management, drug utilization review, prescriber outreach and education, prior authorization, Massachusetts

DOI of Published Version


Journal/Book/Conference Title

American Drug Utilization Review Society 2015



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.